Altimmune (ALT) Stock Price
$3.54 0.3%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Altimmune, AI stock picks, stock alerts and much more.
ALT AI Stock Analysis
AI stock analysis for ALT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Altimmune (ALT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Altimmune (ALT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Altimmune (ALT), currently trading at $3.54, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALT
-
Altimmune, Inc.
-
Symbol
ALT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
312.4M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.08 2.5% |
8 |
 |
Inovio Pharmaceuticals INO |
$1.96 2.6% |
3 |
 |
Moderna MRNA |
$27.12 3.4% |
3 |
 |
Anavex Life Sciences AVXL |
$9.53 0.2% |
5 |
 |
BridgeBio Pharma BBIO |
$49.08 2.3% |
6 |
News
ALT Alternative Data
Web Traffic
Altimmune receives an estimated 168101 monthly visitors to altimmune.com.
-
Web Traffic
168101
-
Change from Previous Month
21.9%
-
3 Month Change
12.1%
-
YoY Change
12.1%
Twitter Followers
Altimmune has 1,747 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.9% over the last month.
-
Twitter Followers
1747
-
Daily Change
0.1%
-
1 Month Change
0.9%
-
3 Month Change
9.9%
-
YoY Change
9.9%
LinkedIn Followers
6,518 are following Altimmune on LinkedIn, up by 1.5% over the last month.
-
LinkedIn Followers
6518
-
Daily Change
0%
-
1 Month Change
1.5%
-
3 Month Change
5.1%
Job Postings
Altimmune currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Altimmune has 78 employees.
-
LinkedIn Employees
78
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.3%
-
YoY Change
1.3%
Reddit Mentions
Altimmune has been mentioned an estimated 2 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Sentiment
The sentiment Score for Altimmune is 86 out of 100, which represents a bullish sentiment.
-
Reddit Sentiment
86.1667
-
Daily Change
83.3%
-
1 Month Change
0%
News Mentions
Altimmune was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
ALT Financials
ALT Key Metrics
-
Total Revenue
$5K
-
Net Income
-$23.2M
-
Earnings per Share
-$0.33
-
Free cash flow
-$18.3M
-
EBITDA
-$23.1M
-
EBITDA Ratio
-4629.2
-
Total Assets
$139.3M
ALT 2-year Revenue & Income
ALT 2-year Free Cash Flow
ALT Technicals
ALT SMA
ALT RSI
FAQ
What's the current price of Altimmune (ALT) Stock?
The price of an Altimmune (ALT) share is $3.54.
What's the market cap of Altimmune?
The current market cap of Altimmune is 312.4M.
Should I buy or sell ALT?
Altimmune shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Altimmune is better viewed as a hold or accumulate position while waiting for further developments.
Is Altimmune a good investment?
The current analysis of Altimmune's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Altimmune's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Altimmune (ALT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Altimmune stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Altimmune (ALT) that investors often compare it to?
Altimmune (ALT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Altimmune's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Altimmune's stock price to be around $3.45 in 2026. Starting from the current price of $3.54, this represents a 2.6% change in price, indicating a neutral outlook for the stock.
How to buy Altimmune (ALT) Stock?
Altimmune stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Altimmune shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.